You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Express Scripts
McKinsey
Mallinckrodt
Dow
Boehringer Ingelheim
AstraZeneca

Last Updated: October 22, 2020

DrugPatentWatch Database Preview

Colestipol hydrochloride - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic sources for colestipol hydrochloride and what is the scope of patent protection?

Colestipol hydrochloride is the generic ingredient in three branded drugs marketed by Pharmacia Upjohn and Impax Labs, and is included in four NDAs. Additional information is available in the individual branded drug profile pages.

There are two drug master file entries for colestipol hydrochloride. Four suppliers are listed for this compound.

Summary for colestipol hydrochloride
Recent Clinical Trials for colestipol hydrochloride

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Laboratorios Grossman, S.A.Phase 3
Instituto Nacional de Salud Publica, MexicoPhase 3
University of South FloridaPhase 1

See all colestipol hydrochloride clinical trials

Pharmacology for colestipol hydrochloride
Medical Subject Heading (MeSH) Categories for colestipol hydrochloride

US Patents and Regulatory Information for colestipol hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacia Upjohn COLESTID colestipol hydrochloride TABLET;ORAL 020222-001 Jul 19, 1994 AB RX Yes Yes   Start Trial   Start Trial   Start Trial
Impax Labs COLESTIPOL HYDROCHLORIDE colestipol hydrochloride GRANULE;ORAL 077277-001 May 2, 2006 AB RX No No   Start Trial   Start Trial   Start Trial
Impax Labs COLESTIPOL HYDROCHLORIDE colestipol hydrochloride TABLET;ORAL 077510-001 Oct 24, 2006 AB RX No No   Start Trial   Start Trial   Start Trial
Pharmacia Upjohn FLAVORED COLESTID colestipol hydrochloride GRANULE;ORAL 017563-001 Approved Prior to Jan 1, 1982 RX Yes No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for colestipol hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pharmacia Upjohn FLAVORED COLESTID colestipol hydrochloride GRANULE;ORAL 017563-001 Approved Prior to Jan 1, 1982   Start Trial   Start Trial
Pharmacia Upjohn COLESTID colestipol hydrochloride TABLET;ORAL 020222-001 Jul 19, 1994   Start Trial   Start Trial
Pharmacia Upjohn FLAVORED COLESTID colestipol hydrochloride GRANULE;ORAL 017563-002 Approved Prior to Jan 1, 1982   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Medtronic
Express Scripts
McKinsey
AstraZeneca
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.